Medical network - Feb. 9, according to data by the late February 8, 212 in a-share listed pharmaceutical companies, the existing 183 disclosure of earnings forecast in 183. Among them, 123 net profit rose, 50 fell, 10 uncertain. Basic get harvest, pharmaceutical industry listed companies means that the pharmaceutical industry gradually spend winter showed signs of recovery.
123 companies performance prediction
Statistics show that 183 companies operating income compared with average growth of about 7.5%, year-on-year net profit year-on-year growth of about 10% on average.
In net profit forecast of 123 companies, 38 growth to exceed 100%, including the appropriate wide reputation far, national agricultural science and technology, China health, pharmaceutical, tai chi group, etc. Growth performance of these companies is generally the reason is that the expansion of sales and bring new profit growth, product launches and denotative expansion and growth after the table.
Among them, nine Ann medical and pharmaceutical belong to northeast turnround type, the rest of the company net profit basic in one hundred million yuan of above. Wide reputation far to 47 times is expected to rise a coppi, expected net profit of 98 million yuan.
30 companies expected net profit growth of between 30% and 100%, including er kang pharmaceutical, will stock, the letter states pharmaceutical, bo teng, daughter pharmaceuticals, east pharmaceuticals, etc. These companies more for acquisition of the assets and net profit rose or sales scale.
In addition, 50 companies are expected to decline in net profit, including jia should pharmaceutical, double heron important pharmaceutical company, jianmin group, the east, the sea pury, etc. Among them, the step length pharmaceuticals listed in November 2016.
Pharmaceutical industry cold winter is over
Chinese medicine enterprise management association ming-de yu told the China securities journal reporter, in the first half of 2015 the pharmaceutical manufacturing industry revenue growth is a new low for nearly 15 years, the growth rate is only 8.76%. Industry revenue growth rate fell below 10% of the time, just before 2000. It is because of lack of medical insurance system for urban employees. But in 2003, 2007 new farmers, urban residents medical insurance has been set up, in the aging demand constantly released today, it is worth noting that dropped below double-digit growth. In the first half of 2016, pharmaceutical manufacturing industry revenue growth of 10%, to return to double-digit levels, recovered from a year earlier.
As health control exertion increase year by year, pharmaceutical industry relies on the golden age of health-care invincible development has in the past. Pharmaceutical industry is facing challenges, hospital medicine proportion is more and more small, the drug bidding price and auxiliary, antibiotics, including large infusion strengthening limits, etc. Agricultural bank, however, the medical care fund fund manager Xu Zhibiao thinks, medicine plate is high cost performance, industry nadir is in the past. |
